Drugs Made In America Acquisition DMAA
NASDAQ DMAA
$10.75 +0.02 (+0.23%)
As of: Aug 21, 2026 · 2:31 PM EDT

Drugs Made In America Acquisition (DMAA) Shares Outstanding (2024 - 2025)

Drugs Made In America Acquisition's (DMAA) quarterly Shares Outstanding (Entity) came in at $21.0 million in Q4 2025, up 113.13% YoY from $9.9 million in Q4 2024, and down 8.66% on a QoQ basis from $23.0 million in Q3 2025.

Drugs Made In America Acquisition (DMAA) Shares Outstanding (2024 - 2025) Analysis & Trends

Drugs Made In America Acquisition (DMAA) has 2 years of Shares Outstanding (Entity) data on file, last reported at $21.0 million in Q4 2025.

  • Quarterly Shares Outstanding (Entity) rose 113.13% year-over-year to $21.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $21.0 million (up 113.13% YoY) and the FY2025 annual result came in at $21.0 million, up 113.13% from the prior year.
  • Shares Outstanding (Entity) fell to $21.0 million in Q4 2025, from $23.0 million in the prior quarter.
  • In the past five years, Shares Outstanding (Entity) ranged from a high of $23.0 million in Q2 2025 to a low of $9.9 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Oxley Bridge Acquisition 585.76 Mn 585.76 Mn - 25.30 Mn
2 Launch Two Acquisition 557.86 Mn 557.86 Mn - 23.00 Mn
3 Drugs Made In America Acquisition 507.00 Mn 507.00 Mn - 50.00 Mn
4 Cantor Equity Partners IV 468.00 Mn 468.00 Mn - 45.00 Mn
5 GP-Act III Acquisition 401.06 Mn 401.06 Mn - 22.84 Mn
6 Aldel Financial 397.49 Mn 397.49 Mn - 23.00 Mn
7 Republic Digital Acquisition 389.25 Mn 388.51 Mn - 30.00 Mn
8 Gores Holdings X 385.06 Mn 384.87 Mn - 35.88 Mn
9 Agriculture & Natural Solutions Acquisition 377.29 Mn 377.04 Mn - 32.92 Mn
10 Drugs Made In America Acquisition 215.82 Mn 215.82 Mn - 20.10 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 21.01 Mn
Sep 30, 2025 23.00 Mn
Jun 30, 2025 23.00 Mn
Mar 31, 2025 15.18 Mn
Dec 31, 2024 8.57 Mn